ArticleScientific reports2025
A biocompatible propolis pollen and ZnO nanorod composite with antimicrobial and antibiofilm activity.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hydrogel-Based Delivery of Ion Channel Modulators for Cancer Therapy: Current Advances and Future Perspectives.Gels (Basel, Switzerland) · 2026Review
- Understanding the Effect of Propolis and Its Derivatives AgainstJournal of fungi (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the context of growing infections, plant-derived natural compounds play a crucial role in the search for new antimicrobial agents, as they offer a diverse array of bioactive molecules. Similarly, nanomaterials, particularly those based on zinc oxide, hold great potential for biomedical applications due to their unique properties. This study evaluates the antimicrobial efficacy of a formulation combining propolis, pollen, and ZnO nanorods (PrPoZnO). SEM and FTIR analysis confirmed ZnO nanorod integration within the propolis-pollen matrix. Antimicrobial testing revealed significant inhibitory effects on Staphylococcus aureus and Pseudomonas aeruginosa, with viability reduction of up to 85% and biofilm inhibition of 50% and 40%, respectively. The PrPoZnO mixture also reduced Candida albicans growth by 90%, inhibited biofilm formation by 60%, and suppressed the yeast-to-hyphae transition, a key virulence factor. Furthermore, the biocompatibility testing of the PrPoZnO mixture in several cell lines demonstrated no cytotoxic effects at the higher concentration, suggesting its potential for safe biomedical applications. In terms of mechanism, PrPoZnO modulated oxidative stress responses, decreasing ROS levels in bacteria while inducing ROS production in C. albicans, suggesting that ZnO nanorods are the key player to induce mechanical damage of microbes. These findings underscore the potential of PrPoZnO as an innovative and biocompatible compound, supporting its suitability for further clinical investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.